ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 191 filers reported holding ASCENDIS PHARMA A/S in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,364,324 | -27.4% | 50,031 | -17.3% | 0.05% | -20.0% |
| Q4 2022 | $7,387,033 | +51.3% | 60,485 | +27.9% | 0.06% | +71.1% |
| Q3 2022 | $4,882,000 | +9.0% | 47,280 | -1.9% | 0.04% | +18.8% |
| Q2 2022 | $4,480,000 | -29.7% | 48,198 | -11.3% | 0.03% | -13.5% |
| Q1 2022 | $6,377,000 | -12.8% | 54,336 | 0.0% | 0.04% | -17.8% |
| Q4 2021 | $7,310,000 | – | 54,336 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |